Karen Costenbader, MD, MPH
Enriched profileDirector, Lupus Program; Chief, Section of Clinical Sciences; Michael E. Weinblatt, MD Distinguished Chair in Rheumatology; Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital
Karen Costenbader is Director, Lupus Program; Chief, Section of Clinical Sciences; Michael E. Weinblatt, MD Distinguished Chair in Rheumatology; Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 473 publications with 42,017 citations (h-index 81); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Karen H. Costenbader, MD MPH, is Director, Lupus Program at Brigham and Women's Hospital / Harvard Medical School, Division of Rheumatology, Inflammation and Immunity, Boston, MA. The public record shows 473 publications with 42,017 citations (h-index 81), centered on Osteoarthritis, Rheumatoid Arthritis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 9 companies, 8 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2026 · Arthritis & rheumatology (Hoboken, N.J.)
- Top research focus: Osteoarthritis
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 76 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Sponsor: Brigham and Women's Hospital
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20253 payments
- GlaxoSmithKline, LLC.Program year20253 payments
- UCB SAProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
37.8%Folate Analog Metabolic Inhibitor24.4%Methotrexate100%Part D<11 patientsSelective T Cell Costimulation Modulator13.4%Orencia Clickject100%Part D<11 patientsAntiparasitic
29.3%Antimalarial29.3%Hydroxychloroquine Sulfate100%Part D<11 patientsMetabolism & gastrointestinal
18.3%Corticosteroid18.3%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
8 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- GENE ENVIRONMENT TRIGGERS AND PROTEOMIC PATHWAYS MEDIATING ANTI-NUCLEAR AUTOIMMUNITY AND SYSTEMIC RHEUMATIC DISEASE
University of Houston
FY2026$667,276R01AR086872 - Dapagliflozin in Active Lupus Nephritis: A Pilot and Feasibility Randomized Trial
Brigham and Women'S Hospital
FY2026$364,560R01DK145763 - Elucidating Social Determinants and Mental Health Needs to Achieve Equity in Rheumatic Disease Care
Brigham and Women'S Hospital
FY2023$358,000R03AR083661
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Testing the Possibility of Preventing Systemic Lupus Erythematosus.
Arthritis & rheumatology (Hoboken, N.J.)
Editorial2026 - Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials.
Lupus science & medicine
Review2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/karen-costenbader-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Karen-Costenbader
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/reel/DBwY6wdtXx1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - X / Twitter
x.com/ACR_Journals
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- MPH
Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Master's degree
University of Cambridge, England
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗
Editorial & leadership roles
journal and society appointments- Deputy Editor
Arthritis & Rheumatology (ACR journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →worldmedicalinnovation.org ↗
Secondary affiliations
appointments beyond the home institution- Chair
Medical-Scientific Advisory Council, Lupus Foundation of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Faculty
Pri-Med (CME provider)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- "Karen Costenbader, MD: Data Supports Belimumab as Treatment in Early Lupus"
HCPLive/Rheumatology Live video interview
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheum-live.com ↗ - COVID-19 impact on lupus patients interview
BWH Lupus Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.bwh.harvard.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital